Rep. Murphy Introduces the POPCaP Act to Expand Precision Cancer Care for Veterans
The POPCaP Authorization Act of 2026 is currently in the early stages of the legislative process. It was recently introduced and sent to the House Committee on Veterans Affairs for review. No further actions are scheduled at this time, and the bill is considered to be actively moving.
Veterans' health bills often get bipartisan support, but many bills introduced in the House struggle to get a full vote or pass the Senate during a busy session.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The bill requires each Center of Excellence to employ at minimum a medical oncologist, interventional radiologist, urologist, radiation oncologist, pathologist, and two full-time research staff. The Program Leadership team also requires an Executive Director, Clinical Director, and Research Director. This would create new specialized positions for VA employees and researchers at 28 designated facilities, and protects existing prostate cancer staff from being removed until 2030.
“The Secretary of Veterans Affairs may not remove from any medical facility designated as a Center of Excellence under section 7330D of title 38, United States Code, any staff, program, or function relating to prostate cancer that was in effect on January 1, 2023, until January 1, 2030.”
Referred to the House Committee on Veterans' Affairs.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
POPCaP Authorization Act of 2026
Analysis generated by AI. Always verify with official sources.